Article citationsMore>>
Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G.F., Coats, A.J.S., Falk, V., Gonzalez-Juanatey, J.R., Harjola, V.P., Jankowska, E.A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J.T., Pieske, B., Riley, J.P., Rosano, G.M.C., Ruilope, L.M., Ruschitzka, F., Rutten, F.H., van der Meer, P. and Group ESCSD (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) Developed with the Special Contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37, 2129-2200.
https://doi.org/10.1093/eurheartj/ehw128
has been cited by the following article:
-
TITLE:
Iron Succinate Increased Ferritin and Transferrin Saturation in Non-Anaemic Patients with Heart Failure and Iron Deficiency—A Pilot Study
AUTHORS:
Kurt Boman, Mona Olofsson
KEYWORDS:
Iron Deficiency, Non-Anemic, Heart Failure, Iron Succinate
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.11 No.1,
January
13,
2021
ABSTRACT:
Introduction: Iron deficiency (ID) is often present (32% - 65%) in patients with heart failure (HF). Oral iron absorption in patients with HF is generallypoor. This is the reason why oral treatment is not recommended. Aim: To test whether oral iron succinate significantly increases iron deposits in non-anaaemic patients with HF. Methods: ID was defined as ferritin 2+ plus 100 mg succinate) in the morning and one tablet at bedtime for at least 3 months. Hemoglobin, CRP, ferritin, iron, TSAT, and hepcidin were analyzed before starting treatment, at 6 weeks, and at 3 months end of study (EOS). Results: Five women and 15 men were included in the study. The level of ferritin increased significantly from baseline to 6 weeks (47 to 78 μg/L, p = 0.009) and baseline to EOS (47 to 85 μg/L, p = 0.001). TSAT increased significantly from baseline to 6 weeks (20% to 27%, p = 0.046) and baseline to EOS (20% to 25%, p = 0.043). Hepcidin increased significantly from baseline to 6 weeks (2.5 nmol/L to 4.8 nmol/L, p = 0.006) and baseline to EOS (2.5 to 4.2 nmol/L, p = 0.02). Conclusion: Oral iron succinate significantly increased iron uptake, almost doubling the ferritin levels and increasing the TSAT, in patients with HF. Our findings challenge the opinion that oral iron treatment cannot significantly increase iron deposits in non-anemic patients with ID and HF.
Related Articles:
-
Lipy Lucy Costa, Md. Shariful Islam, Mohammad Nurul Anowar, Md. Abdul Latif
-
Arnon Blum, Rizak Sirchan, Lital Keinan-Boker
-
Mattia A. E. Valente, Adriaan A. Voors
-
Haruka Otsu, Toshiko Inoguchi, Michiko Moriyama, Shigeko Takayama, Yoko Watanabe, Masayo Kume
-
José Fernando Guadalajara-Boo